Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Merck

148.46
-1.8700-1.24%
Post-market: 148.28-0.1841-0.12%19:59 EDT
Volume:11.19M
Turnover:1.66B
Market Cap:366.28B
PE:116.64
High:149.60
Open:148.41
Low:146.28
Close:150.33
52wk High:156.92
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.37
T/O Rate:0.45%
Dividend:3.32
Dividend Rate:2.24%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.73
PE(LYR):20.39

Loading ...

OverviewCompanyNewsFilings

U.S. Stocks on the MOVE-Marvell, Pilgrim's Pride, ServiceNow

Reuters
·
Aug 19

Top Midday Stories: Treasury Lifts Buyback Cap on Long-Dated Securities; Moderna, Merck Say Melanoma Vaccine Meets Primary Endpoint in Trial

MT Newswires Live
·
Aug 19

Moderna Moves Back Toward Covid-Era Valuation with Latest mRNA Update

Dow Jones
·
Aug 19

Dow Rallies 314 Points on Gains for Merck, Salesforce Stocks

Dow Jones
·
Aug 19

Leerink says cancer vaccine win should sustain Merck momentum into fall

TIPRANKS
·
Aug 19

Moderna's Experimental Vaccine Prevents Cancer Recurrence, in 'historic' Win for Personalized Medicine. Its Stock is Soaring.

Dow Jones
·
Aug 19

Instant VIEW-Moderna-Merck Melanoma Vaccine Data Boosts Outlook, but Analysts Await Full Results

Reuters
·
Aug 19

Early notable gainers among liquid option names on August 19th

TIPRANKS
·
Aug 19

Moderna’s Gain Widens To 150%, MRK Rises More Than 12%, BioNTech Climbs Over 24%

Tiger Newspress
·
Aug 19

Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Moderna (MRNA) and Merck & Company (MRK)

TIPRANKS
·
Aug 19

Merck up over 9%, on Track for Record High Close

Dow Jones
·
Aug 19

Merck & Co Inc Stock (MRK) Opened Up by 8.82% on Aug 19: Key Drivers Unveiled

TradingKey
·
Aug 19

Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb

Dow Jones
·
Aug 19

Moderna Stock Price Doubles on Melanoma Vaccine News

Dow Jones
·
Aug 19

Merck Shares Touch Record High, Last up 9.6%

THOMSON REUTERS
·
Aug 19

Shares of Moderna Rise 87%, Merck Rise 6.8% After Skin Cancer Vaccine Succeeds in Late-Stage Trial

THOMSON REUTERS
·
Aug 19

Movement Alert｜Merck Rises 8.75% in Regular Trading, Phase III Melanoma Vaccine Trial Meets Primary Endpoint

Market Focus
·
Aug 19

Sector Update: Healthcare

MT Newswires Live
·
Aug 19

Biotech Stocks Jump Premarket After Moderna's Melanoma Vaccine with Merck Succeeds in Large Trial

THOMSON REUTERS
·
Aug 19

The Bond Selloff is Rattling Investors, but Here's Why They Shouldn't Expect a Deeper Stock Downturn

Dow Jones
·
Aug 19
More